STUDI PENGGUNAAN CALCIUM CHANNEL BLOCKER (CCB) PADA PASIEN STROKE HEMORRAGHIC

  • Utami N
  • Hasmono D
  • Yusetyani L
N/ACitations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

ABSTRAK Stroke adalah penyakit yang dapat menyebabkan kematian di dunia. Di Indonesia, dapat menyebabkan stroke yaitu hipertensi sehingga diperlukan antihipertensi, Metode penelitian yang dilakukan yaitu studi observasi dengan menggunakan sampel menunjukkan penggunaan CCB yaitu nicardipine 64%, nimodipine 12%, amlodipine 2%, dan diltiazem 6%. ABSTRACT Stroke is a disease that cause of big enough deaths in the world. In Indonesia, population of patient who have stroke reached 8.3 ‰. Highest risk factors that cause stroke is hypertension so needed a antihypertensive therapy, one of which is the class of CCB. The purpose of this study is to investigate the pattern of use Calcium Channel Blocker (CCB) in patients with hemorrhagic stroke hospitalizations in RSU Dr. Saiful Anwar Malang. Research Methods was an observational study, which employed a retrospective descriptive method. analysis was performed at January to December 2012 at patients medical records was diagnosed stroke hemorrhagic and CCB receiving antihypertensive therapy too. Results and Conclusions of the 54 samples, the CCB group most widely used in a sequence that is nicardipine 64%, nimodipine 12%, amlodipine 2%, and diltiazem 6%.

Cite

CITATION STYLE

APA

Utami, N., Hasmono, D., & Yusetyani, L. (2013). STUDI PENGGUNAAN CALCIUM CHANNEL BLOCKER (CCB) PADA PASIEN STROKE HEMORRAGHIC. Media Farmasi: Jurnal Ilmu Farmasi, 10(2). https://doi.org/10.12928/mf.v10i2.1174

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free